The recent findings support several actors involved in the neuroinflammatory process underlying MS: translocator protein 18 (TSPO), cannabinoid and adenosine receptors, astrogliosis and sphingosine 1-phosphate receptors. Here, S1PR1 is linked to myeloid sarcoma.